Article Information
History
- February 1, 2019.
Article Versions
- older version (October 11, 2018 - 13:02).
- older version (January 3, 2019 - 22:21).
- You are viewing the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Alicia R Martin1,6 (armartin{at}broadinstitute.org),
- Masahiro Kanai2 (mkanai{at}broadinstitute.org),
- Yoichiro Kamatani3 (yoichiro.kamatani{at}riken.jp),
- Yukinori Okada4 (yokada{at}broadinstitute.org),
- Benjamin M Neale1 (bneale{at}broadinstitute.org) and
- Mark J Daly5 (mjdaly{at}atgu.mgh.harvard.edu)
- 1 Broad Institute & MGH;
- 2 Broad Institute, MGH, Harvard Medical School, & RIKEN;
- 3 RIKEN & Kyoto University;
- 4 RIKEN & Osaka University;
- 5 Broad Institute, MGH, & FIMM
- ↵* Corresponding author; email: armartin{at}broadinstitute.org
Posted February 01, 2019.
Current clinical use of polygenic scores will risk exacerbating health disparities
